Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (69)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (4)
Immunology (32)
Inflammation and immunity (55)
Microbiology (23)
Model Organisms (4)
Mouse (2)
Neuroscience (59)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
Katrina Wright
Tel.: +32 9 244 66 11
Recent press releases
The secret of classic Belgian beers? Medieval super yeasts!
21 October 2019
A team of scientists, led by Kevin Verstrepen (VIB-KU-Leuven) & Steven Maere (VIB-UGent), has discovered that some of the most renowned classic Belgian beers, including Gueuze and Trappist ales, are fermented with a rare form of hybrid yeasts.
Successful microbes: Biotech Day 2019
20 October 2019
Despite the gloomy weather, biotechdag 2019 was a great success. A large number of visitors enjoyed a range of presentations and activities that provided a glimpse into the marvelous world of microbes.
Zooming in on Excellence
16 October 2019
VIB and Nikon are happy to announce that they are extending their partnership, as the VIB-KU Leuven BioImaging Core is becoming a Nikon Center of Excellence. This is good news for the scientific community that has a need for excellent imaging equipment.
A CRISPR Knockout
10 October 2019
A team from the VIB-UGent Center for Plant Systems Biology, led by Thomas Jacobs, Moritz Nowack, and Tom Beeckman has devised a CRISPR-based tissue-specific knockout system, CRISPR-TSKO.
Quickscan 2019
9 October 2019
VIB's scientific publications 3th quarter 2019
ERC’s research funding is really ‘bottom up’
7 October 2019
On October 3rd, an ERC delegation visited the lab of ERC grantee Kevin Verstrepen to learn more about his work funded by the ERC grant YEASTMEMORY.
Immune cells in the spotlight
3 October 2019
VIB and VUB researchers involved in Innovative Medicines Initiative that awards 30 Million Euro grant supporting research into novel tracer strategies for clinical imaging of immune cell dynamics.
Enhancing the societal impact of research
24 September 2019
The goal is not just funding (societal and economical) value creation, but supporting innovative new approaches, addressing societal need gaps, and bringing the right solutions to the places where they are most needed in a dialogue with all stakeholders.
Introducing the Grand Challenges Projects
24 September 2019
VIB’s Grand Challenges Program has been set up, supported by a crucial investment from the Flemish Government, to increase the societal impact of VIB by addressing scientific challenges with a substantial significance.
Primary Immune Deficiencies
24 September 2019
Primary immune deficiency diseases (PIDs) are a heterogeneous group of life-threatening genetic disorders of the innate & adaptive immune system. There is still a lot of under-diagnosis as PIDs are very complex and can present clinically in many forms.
Improved diagnosis of liver disease
24 September 2019
Chronic liver disease is a major cause of morbidity & mortality worldwide, with increasing prevalence. In terms of total years of life lost, it is the thirteenth most burdensome disease & the fifth leading; cause of death in the young adult age group.
POINTILLISM
24 September 2019
Today, the spiraling prices of immuno-oncology agents threaten the financial sustainability of cancer treatment. This situation has only worsened since it became clear that these drugs need to be combined for optimal clinical results.
Mimosa: microbiota against inflammatory bowel disease
24 September 2019
Inflammatory bowel disease (IBD) is a term to describe conditions that are characterized by chronic inflammation of the bowels, such as Crohn’s disease and ulcerative colitis. IBD occurs in about 8 out of each 1000 people.
Targeting drugs to the brain
24 September 2019
According to the World Health Organization, neurological disorders affect up to one billion people worldwide. These neurological disorders affect people in all countries, irrespective of age, sex, education, or income.
Spartacus better treatment options for spondyloarthritis
24 September 2019
About a fifth of Europeans suffers from musculoskeletal disorders. A substantial subgroup are the rheumatic conditions. Within the rheumatic disorders, spondyloarthritis is a group of inflammatory diseases that cause joint inflammation, or arthritis
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
Next»
Page Content Zone 2
Page Content Zone 3